Q2 2024 · 13F-HR
First Turn Management, LLCholdings as filed
Filed 2024-08-08 · accession 0001085146-24-003570
$614.7M
Reported value
36
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 04016X101 | ARGX | ARGENX SE | $34.4M | 5.59% | 79,978 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $28.7M | 4.67% | 181,669 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $27.1M | 4.42% | 337,246 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $25.4M | 4.14% | 186,581 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $24.0M | 3.91% | 703,398 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $23.8M | 3.87% | 347,343 | Common | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $23.8M | 3.87% | 50,692 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $21.7M | 3.52% | 323,360 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $21.1M | 3.42% | 139,780 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $20.1M | 3.26% | 109,222 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $19.9M | 3.24% | 184,901 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $19.7M | 3.20% | 260,281 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $19.1M | 3.11% | 252,276 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $19.0M | 3.10% | 321,906 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $18.6M | 3.03% | 41,901 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $18.4M | 2.99% | 695,428 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $18.2M | 2.95% | 160,096 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $16.8M | 2.73% | 369,980 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $16.5M | 2.69% | 369,302 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $15.9M | 2.59% | 293,318 | Common | SOLE |
| 02081G201 | ATEC | ALPHATEC HLDGS INC | $14.2M | 2.31% | 1,360,410 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $14.0M | 2.27% | 397,782 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $13.3M | 2.16% | 339,876 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $13.1M | 2.14% | 640,389 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $12.8M | 2.08% | 329,519 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $12.7M | 2.07% | 366,019 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $12.5M | 2.04% | 318,327 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $12.5M | 2.03% | 1,059,540 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $12.1M | 1.96% | 560,989 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $10.9M | 1.78% | 464,435 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $10.7M | 1.74% | 1,515,960 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $10.2M | 1.66% | 537,338 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $9.9M | 1.60% | 291,086 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $9.7M | 1.57% | 413,243 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $7.7M | 1.25% | 212,944 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $6.3M | 1.02% | 138,907 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.